(Q30890134)

English

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

Europe PubMed Central

Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

data collection

1 reference

based on heuristic

inferred from title

Katrin Susanne Kohl

2

object named as

Katrin S Kohl

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Scott A Halperin

4

object named as

Scott A Halperin

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

5

object named as

Neal Halsey

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

author name string

Edward Rothstein

1

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Leslie Ball

3

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Sandra Jo Hammer

6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Paul T Heath

7

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Renald Hennig

8

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Cynthia Kleppinger

9

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Jerry Labadie

10

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Frederick Varricchio

11

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Patricia Vermeer

12

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Wikke Walop

13

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Brighton Collaboration Local Reaction Working Group

14

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

575-585

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

Aluminium hydroxide granuloma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Injection-site granuloma due to aluminum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Postimmunization (vaccination) injection-site reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Aluminium hydroxide granulomas: light and electron microscopic studies and X-ray microanalysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Inflammatory nodular reactions after hepatitis B vaccination due to aluminium sensitization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Workshop summary. Aluminum in vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Aluminum salts in vaccines--US perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Aluminum-containing vaccine associated adverse events: role of route of administration and gender

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type b (Hib) vaccine, a diphtheria-tetanus-whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Adverse reactions associated with simultaneous administration of multiple vaccines to travelers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Safety of revaccination with pneumococcal polysaccharide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Side Effects Associated With Influenza Vaccination in Healthy Working Adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminium content of the vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

An acellular pertussis vaccine in healthy adults: safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Advantages of Aluminium Hydroxide Adsorbed Combined Diphtheria, Tetanus, and Pertussis Vaccines for the Immunization of Infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Granulomas associated with tetanus toxoid immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Aluminium and injection site reactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Vaccination granulomas and aluminium allergy: course and prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.005

7 January 2021

Identifiers

10.1016/J.VACCINE.2003.09.005

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30890134&oldid=1970879994"